Sign inJoin free

Watch / TIP Conference

TIP Conference: ECS Botanics’ German Advantage

TIP Conference7 Nov 202610:20

TIP Conference: ECS Botanics’ German Advantage

General information only. ausbiz videos are general information only, produced by Ausbiz TV Pty Ltd, a media business that doesn’t give financial advice. They don’t take into account your objectives, financial situation or needs. Consider whether it’s right for you and read the PDS and TMD before acting on anything you watch.

About this video

ECS Botanics grows and manufactures medicinal cannabis in north-west Victoria and sells its own branded products to Australian patients through GPs. CEO Nan-Maree Schoerie says the company’s shift from bulk supply to its own brands now makes up more than 70% of the business and has delivered five consecutive quarters of positive operating cash flow. New European rules that require growers to also manufacture on the same site, to EU GMP standards, have cut out most of the global competition and opened up Germany as ECS’s biggest growth market.

Nan-Maree also explains a new profit-sharing deal to take ECS’s flagship brand into the UK through Curaleaf, and the patented delivery technology that makes its oils and capsules around four times more bioavailable. With a market capitalisation of around $8 million against revenue of about $21 million, she talks frankly about why the sector’s reputation has weighed on valuations, and why she’s now focused on telling the ECS story to investors.

More like this

We value your privacy

We use essential cookies to make the site work. Non-essential cookies help us improve the experience. You can accept or reject non-essential cookies. Privacy policy